Analyst Ratings for Chromocell Therapeutics Corp. (CHRO)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/18/2024 | Alliance Global Partners | James Molloy | New Coverage | Buy (N/A) |
N/A (N/A) |
1.26 (1.35) |
7.14% | Details |
